What's new

Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 40, Status: Authorised

Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 40, Status: Authorised

Mar 26, 2025 - 16:33
 0
Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 40, Status: Authorised
Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 40, Status: Authorised
Read More

Tags:

Previous Article

Wave to seek approval of Duchenne drug after mid-stage study data

Next Article

Old Navy innovates with Radar, uses RFID and AI for smarter inventory management

Related Posts

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – December 2025, European Medicines Agency, Amsterdam, the Netherlands, from 17 December 2025, 10:00 (CET) to 17 December 2025, 12:00 (CET)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0

Agenda of the CVMP meeting 11-13 February 2025

Feb 11, 2025  0

Cyramza-H-C-2829-P46-0010 : EPAR - Assessment report

Mar 26, 2025  0